FTSE All-Share
4 955,99
|
-9,39
|
-0,19 %
|
Analysen zu FTSE All-Share-Werten
05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
04.11.24 | AstraZeneca Sell | UBS AG | |
04.11.24 | Unilever Halten | DZ BANK | |
04.11.24 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.11.24 | Shell Neutral | UBS AG | |
01.11.24 | Shell Buy | Goldman Sachs Group Inc. | |
01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
01.11.24 | Shell Overweight | JP Morgan Chase & Co. | |
31.10.24 | Glencore Buy | Deutsche Bank AG | |
31.10.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
31.10.24 | GSK Buy | Deutsche Bank AG | |
31.10.24 | Glencore Buy | Goldman Sachs Group Inc. | |
31.10.24 | Shell Neutral | UBS AG | |
31.10.24 | GSK Neutral | UBS AG | |
31.10.24 | Shell Buy | Jefferies & Company Inc. | |
31.10.24 | Shell Outperform | RBC Capital Markets | |
31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
30.10.24 | BP Buy | UBS AG | |
30.10.24 | GSK Neutral | UBS AG | |
30.10.24 | HSBC Holdings Buy | Deutsche Bank AG | |
30.10.24 | London Stock Exchange Hold | Deutsche Bank AG | |
30.10.24 | GSK Outperform | Bernstein Research | |
30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
30.10.24 | Glencore Outperform | RBC Capital Markets | |
30.10.24 | HSBC Holdings Neutral | UBS AG | |
29.10.24 | BP Sector Perform | RBC Capital Markets | |
29.10.24 | BP Underweight | JP Morgan Chase & Co. | |
29.10.24 | BP Halten | DZ BANK | |
29.10.24 | BP Sector Perform | RBC Capital Markets | |
29.10.24 | BP Buy | UBS AG | |
29.10.24 | HSBC Holdings Sector Perform | RBC Capital Markets | |
29.10.24 | HSBC Holdings Neutral | UBS AG | |
29.10.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
28.10.24 | Unilever Overweight | Barclays Capital | |
25.10.24 | London Stock Exchange Outperform | RBC Capital Markets | |
25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
25.10.24 | Vodafone Group Buy | Deutsche Bank AG | |
25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. |